Vanda Pharmaceuticals Inc.
VNDA
$8.81
-$0.48-5.17%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.57% | -21.93% | -16.03% | -13.51% | -3.51% |
| Total Receivables | 15.87% | 18.22% | 7.47% | 21.49% | 37.90% |
| Inventory | 7.30% | 26.52% | 47.65% | 27.77% | 27.19% |
| Prepaid Expenses | 74.33% | 79.96% | 171.80% | 189.82% | 68.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.88% | -15.01% | -10.08% | -7.17% | 1.37% |
|
|
|||||
| Total Current Assets | -20.88% | -15.01% | -10.08% | -7.17% | 1.37% |
| Net Property, Plant & Equipment | 6.60% | 45.22% | 43.67% | 37.88% | 38.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.62% | -6.05% | -5.96% | -5.87% | -5.99% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -87.76% | 27.31% | 24.27% | 16.91% | 6.54% |
| Total Assets | -25.49% | -6.82% | -4.09% | -3.18% | 1.20% |
|
|
|||||
| Total Accounts Payable | 41.22% | -45.95% | -3.75% | 37.95% | -51.04% |
| Total Accrued Expenses | 52.63% | 28.19% | 43.99% | 12.49% | 8.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 30.09% | 91.04% | 92.83% | 82.32% | 78.07% |
| Total Finance Division Other Current Liabilities | 42.65% | 41.11% | 18.78% | 5.53% | 23.68% |
| Total Other Current Liabilities | 42.65% | 41.11% | 18.78% | 5.53% | 23.68% |
| Total Current Liabilities | 45.19% | 32.30% | 29.53% | 11.34% | 14.01% |
|
|
|||||
| Total Current Liabilities | 45.19% | 32.30% | 29.53% | 11.34% | 14.01% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.65% | 13.51% | 15.90% | 12.85% | 15.47% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.56% | 18.55% | 10.03% | 4.69% | 8.61% |
| Total Liabilities | 37.48% | 30.08% | 27.16% | 10.89% | 13.65% |
|
|
|||||
| Common Stock & APIC | 1.20% | 1.29% | 1.42% | 1.55% | 1.78% |
| Retained Earnings | -126.50% | -49.71% | -40.80% | -27.74% | -12.16% |
| Treasury Stock & Other | 750.00% | -23.08% | 220.00% | 200.00% | 346.67% |
| Total Common Equity | -39.25% | -13.90% | -10.36% | -5.99% | -1.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -39.25% | -13.90% | -10.36% | -5.99% | -1.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -39.25% | -13.90% | -10.36% | -5.99% | -1.17% |
|
|
|||||